ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test
At DNA Labs UAE, we offer the ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test at a cost of AED 3200.0.
Test Details
The ACADVL gene is responsible for encoding the enzyme Acyl-CoA very long-chain dehydrogenase (ACADVL). Deficiency of this enzyme is a rare genetic disorder known as ACADVL deficiency.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ACADVL deficiency, NGS genetic testing can be used to identify mutations or variations in the ACADVL gene that may be associated with the disorder.
By analyzing the entire coding region of the ACADVL gene, NGS testing can provide a comprehensive assessment of genetic variations that may be causing the deficiency. This information can be helpful in confirming a diagnosis, understanding the genetic basis of the disorder, and potentially guiding treatment decisions.
It is important to note that NGS testing is typically performed by specialized laboratories and is ordered by healthcare professionals. The test involves obtaining a sample of DNA, usually through a blood or saliva sample, which is then sequenced using high-throughput sequencing platforms. The resulting data is then analyzed to identify any genetic variations or mutations in the ACADVL gene.
NGS genetic testing has revolutionized the field of genetic diagnostics, allowing for more efficient and cost-effective analysis of multiple genes simultaneously. It has greatly improved the ability to identify and understand genetic disorders like ACADVL deficiency, leading to improved diagnosis and management of affected individuals.
Test Components and Price
Test Name: ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test
Components: NGS Technology
Price: AED 3200.0
Sample Condition
Blood
Report Delivery
3 to 4 Weeks
Test Type
Metabolic Disorders
Doctor
General Physician
Test Department
Genetics
Pre Test Information
A Genetic Counselling session is required to draw a pedigree chart of family members affected with Acyl-CoA very long-chain dehydrogenase deficiency before undergoing the ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency NGS Genetic DNA Test. This will provide valuable information about the family history and help in understanding the inheritance pattern of the disorder.
Test Name | ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test |
---|---|
Components | |
Price | 3200.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Acyl-CoA very long-chain dehydrogenase deficiency |
Test Details |
ACADVL gene is responsible for encoding the enzyme Acyl-CoA very long-chain dehydrogenase (ACADVL). Deficiency of this enzyme is a rare genetic disorder known as ACADVL deficiency. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ACADVL deficiency, NGS genetic testing can be used to identify mutations or variations in the ACADVL gene that may be associated with the disorder. By analyzing the entire coding region of the ACADVL gene, NGS testing can provide a comprehensive assessment of genetic variations that may be causing the deficiency. This information can be helpful in confirming a diagnosis, understanding the genetic basis of the disorder, and potentially guiding treatment decisions. It is important to note that NGS testing is typically performed by specialized laboratories and is ordered by healthcare professionals. The test involves obtaining a sample of DNA, usually through a blood or saliva sample, which is then sequenced using high-throughput sequencing platforms. The resulting data is then analyzed to identify any genetic variations or mutations in the ACADVL gene. NGS genetic testing has revolutionized the field of genetic diagnostics, allowing for more efficient and cost-effective analysis of multiple genes simultaneously. It has greatly improved the ability to identify and understand genetic disorders like ACADVL deficiency, leading to improved diagnosis and management of affected individuals. |